Antiobesity Effect of Lactobacillus Reuteri 263 Associated with Energy Metabolism Remodeling of White Adipose Tissue in High-energy-diet-fed Rats
Overview
Nutritional Sciences
Authors
Affiliations
Obesity is a serious and costly issue to the medical welfare worldwide. Probiotics have been suggested as one of the candidates to resolve the obesity-associated problems, but how they combat obesity is not fully understood. Herein, we investigated the effects of Lactobacillus reuteri 263 (L. reuteri 263) on antiobesity using four groups of Sprague-Dawley rats (n=10/group), namely, C (normal diet with vehicle treatment), HE [high-energy diet (HED) with vehicle treatment], 1X (HED with 2.1×10 CFU/kg/day of L. reuteri 263) and 5X (HED with 1.05×10 CFU/kg/day of L. reuteri 263), for 8 weeks. L. reuteri 263 improved the phenomenon of obesity, serum levels of proinflammatory factors and antioxidant enzymes. More importantly, L. reuteri 263 increased oxygen consumption in white adipose tissue (WAT). The mRNA expressions of thermogenesis genes uncoupling protein-1, uncoupling protein-3, carnitine palmitoyltransferase-1 and cell death-inducing DFFA-like effector-a were up-regulated in WAT of the 5X group. Moreover, L. reuteri 263 might induce browning of WAT due to the higher mRNA levels of browning-related genes peroxisome proliferator-activated receptor-γ, PR domain containing-16, Pparγ coactivator-1α, bone morphogenetic protein-7 and fibroblast growth factor-21 in the 1X and 5X groups compared to the HE group. Finally, L. reuteri 263 altered the expressions of genes involved in glucose and lipid metabolisms in WAT, including increasing the levels of glucose transporter type 4 and carbohydrate-responsive element-binding protein and decreasing the expression of Acetyl-CoA carboxylase-1. The results suggest that L. reuteri 263 may treat obesity through energy metabolism remodeling of WAT in the high-energy-diet-induced obese rats.
The Impact of on Oral and Systemic Health: A Comprehensive Review of Recent Research.
Liu Z, Cao Q, Wang W, Wang B, Yang Y, Xian C Microorganisms. 2025; 13(1).
PMID: 39858814 PMC: 11767923. DOI: 10.3390/microorganisms13010045.
Lactobacillus reuteri ZJ617 attenuates metabolic syndrome via microbiota-derived spermidine.
Ma Y, Zhong Y, Tang W, Valencak T, Liu J, Deng Z Nat Commun. 2025; 16(1):877.
PMID: 39837844 PMC: 11750987. DOI: 10.1038/s41467-025-56105-4.
L11 and LR: Ameliorate Obesity via AMPK Pathway.
Liang S, Sun J, Gu X, Zhao Y, Wang X, Tao H Nutrients. 2025; 17(1.
PMID: 39796438 PMC: 11723306. DOI: 10.3390/nu17010004.
Mehranfar S, Tarashi S, Hajishizari S, Ahmadi Badi S, Yekaninejad M, Clark C J Diabetes Metab Disord. 2024; 23(1):931-941.
PMID: 38932806 PMC: 11196539. DOI: 10.1007/s40200-023-01368-1.
Postbiotic potential of KMU01 cell-free supernatant for the alleviation of obesity in mice.
Shin H, Kim J, Jung Y, Kwak M, Sung M, Imm J Heliyon. 2024; 10(5):e25263.
PMID: 38495172 PMC: 10943329. DOI: 10.1016/j.heliyon.2024.e25263.